Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related deaths. Incidences of early CRC cases are increasing annually in high-income countries, necessitating effective treatment strategies. Immune checkpoint inhibitors (ICIs) have shown significant clin...
Main Authors: | Ronald Heregger, Florian Huemer, Markus Steiner, Alejandra Gonzalez-Martinez, Richard Greil, Lukas Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/20/5090 |
Similar Items
-
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
by: Vito Amodio, et al.
Published: (2021-05-01) -
Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer
by: Camille Evrard, et al.
Published: (2019-10-01) -
Immunotherapy with Immune Checkpoint Inhibitors for Advanced Colorectal Cancer: A Promising Individualized Treatment Strategy
by: Ying Yang, et al.
Published: (2023-04-01) -
Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review
by: Lena Bohaumilitzky, et al.
Published: (2020-06-01) -
Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
by: Sandrine Rousset-Rouviere, et al.
Published: (2021-06-01)